November 2017


In this Supplement

Zenith® Fenestrated

The first FDA-approved option for treating ≥ 4mm short-necked infrarenal AAA.



Fall Supplement

Download a PDF of this supplement

ZFEN Technology: Why It Works and What's in Its Future

By Gustavo S. Oderich, MD

FEVAR: Long-term Data From the Cleveland Clinic

Continued development and application of fenestrated endovascular technology to treat complex aortic disease and directions for the future.

By Matthew J. Eagleton, MD

Ten Steps

A standardized 10-step approach to the planning and sizing of a fenestrated endovascular aortic aneurysm repair.

By Jessica P. Simons, MD, MPH; and Andres Schanzer, MD

Use of ZFEN in Community Practice

The current state of treatment for complex abdominal aortic aneurysms in community practice using the Zenith Fenestrated stent graft.

By Jesse Manunga, MD

Recommendations From a Busy Fenestrated Practice

The top 10 lessons we have learned for optimizing clinical outcomes.

By Gustavo S. Oderich, MD; Emanuel Tenorio, MD, PhD; and Giuliano Sandri, MD

State of the Art in Radiation Safety During Fenestrated EVAR

A discussion of radiation exposure during FEVAR.

By Melissa Kirkwood, MD; David Timaran, MD; and Carlos Timaran, MD

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.